(1-Isopropyl-1H-pyrazol-4-yl)boronic acid

Catalog No.: 
ACBIMK258
CAS No.: 
1201643-90-4
Molecular Formula: 
C6H11BN2O2
Molecular Weight: 
153.98
(1-Isopropyl-1H-pyrazol-4-yl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$58.00In stockInquiry
5g97%$207.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1-Isopropyl-1H-pyrazol-4-yl)boronic acid
IUPAC Name(1-isopropyl-1H-pyrazol-4-yl)boronic acid
MDL No.MFCD16036118
Molecular FormulaC6H11BN2O2
Molecular Weight153.98
SMILESCC(N1N=CC(B(O)O)=C1)C
InChI KeyVLVZNLMUFJYZDG-UHFFFAOYSA-N
SynonymAKOS006333904 | DTXSID90681761 | SY022591 | [1-(PROPAN-2-YL)-1H-PYRAZOL-4-YL]BORONIC ACID | AM90022 | 1-isopropyl-1H-pyrazole-4-boronic acid | 1-ISOPROPYL-1H-PYRAZOL-4-YLBORONIC ACID | AS-68984 | 1-Isopropyl-4-pyrazoleboronic Acid | (1-propan-2-ylpyrazol-
CAS No.1201643-90-4
PubChem CID53216602

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACBIMK258 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRCWX846 route compound structure diagram
    ACRCWX846763120-58-7In Stock
  4. Then
  5. ACBIMK258 route product structure diagram
    ACBIMK2581201643-90-4In Stock
Inquiry

2. ACBIMK258 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBIMK258 route product structure diagram
    ACBIMK2581201643-90-4In Stock
Inquiry

3. ACBIMK258 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBIMK258 route product structure diagram
    ACBIMK2581201643-90-4In Stock
Inquiry

Comments (0)